Explore web search results related to this domain and discover relevant information.
A single point of access to easily and securely interact with local and national public services, directly from your smartphone. With IO, administrations contact citizens through a single app, enabling them to manage operations related to a specific service quickly, punctually and securely from the comfort of their smartphone or tablet.IO changes the way public services are delivered, putting the citizen at the center of the relationship with public entities and institutions.
Find the latest IO Biotech, Inc. (IOBT) stock quote, history, news and other vital information to help you with your stock trading and investing. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer.It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers.IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform.In addition, the company develops IO170, a TGFß1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.
Latest news coverage, email, free stock quotes, live scores and video are just the beginning. Discover more every day at Yahoo! News · Finance · Sports · More · -1 · Manage your account · Help · Add or switch accounts · Sign out · Search the web · Advertisement · Advertisement · Advertisement · Developing · Get email alerts · Get email alerts for future breaking stories.News · Finance · Sports · Mail · Search · Weather · Games · Shopping · Creators · Entertainment · Life · Newsletters · Feedback · LIVE · Yahoo News56.7K · ABC News3K · Yahoo News258 · Rolling Stone518 · US · The Hill1043 min read · Advertisement ·
While I am both anxious and excited about the responsibility of the substantial work ahead, I am so grateful for the opportunity to be part of such an important collaboration. The values and vision of Sam and the teams at OpenAI and io are a rare inspiration.”Jony Ive We’re thrilled to share that the io Products, Inc. team has officially merged with OpenAI.It became clear that our ambitions demanded an entirely new company. And so, one year ago, Jony founded io with Scott Cannon, Evans Hankey and Tang Tan.As the io Products, Inc.Building a family of AI products for everyone.
For custom plan requirements, contact us at contact@gnews.io or use the contact form on our main page. Custom plans are paid only and must include features beyond what the Essential plan offers. ... Our historical news archive goes back to 2020. You can access and search through news articles, headlines, and content from 2020 onwards through our API and platform. I want to filter the results by source, is this possible? This feature is not currently available. Source filtering is not yet supported in our system. ... If you're unable to verify your email address, contact us at [email protected] for assistance.News API to search articles from 60,000+ worldwide sources. Get real-time news and 5 years of historical data in JSON format. Start free.Yes, you can cancel your subscription anytime at no extra cost. Go to your "Plan & Billing" page (gnews.io/plan-billing), find the "Subscription" section, and click the "Cancel subscription" button to confirm your cancellation.You have access to a 10-day free trial to test all paid features. You can start your trial at gnews.io/change-plan and cancel anytime during the trial period.
Consulta toda la información sobre IO Interactive y últimas noticias. Todo sobre IO Interactive, en La Vanguardia. Hakan Abrak, CEO de IO Interactive: “Queremos sumergirte en la fantasía de ser James Bond” La nueva aventura del agente 007 está siendo desarrollada por IO Interactive y llegará a lo largo de 2026Albert García05/06/2025 19:16El estudio danés IO Interactive promete lanzar nuevos contratos durante los próximos mesesMarc Brugat05/02/2021 10:37El nuevo título de IO Interactive se puede jugar en PS4, PS5, Xbox One, Xbox Series X/S, PC, Google Stadia y Nintendo SwitchMarc Brugat25/01/2021 14:10El nuevo título de IO Interactive se puede jugar en PS4, PS5, Xbox One, Xbox Series X/S, PC, Google Stadia y Nintendo SwitchMarc Brugat20/01/2021 10:25
PRNEWS.IO allows brands to publish articles in the top-tier media and publishers of news sites to receive rewards. It’s an all-in-one service for creating and sharing news and stories with the whole world ... PRNEWS.IO is a user-friendly PR platform created to share your news in just a few simple steps.Businesses can directly purchase spots for their native format articles in 100,000 well-regarded news websites. Using automation, PRNEWS.IO has removed the need for a middleman, simplified the process, and improved responsiveness when compared with traditional news distribution methodologies.A wealth of audience metrics from across its marketplace of news websites is built into its automated system. Accordingly, while it is not a traditional PR consulting or management firm, PRNEWS.IO can suggest media options to customers based on analysis of this data, who can opt for longer term campaigns or one-off spots.PRNEWS.IO helps me determine whether a sponsored post is justified, and if so, the marketplace allows me to do it with just one click. This means I don't need to waste time on communication with the editors of those sites.
Matthew Wilson 4 days ago Featured Tech News, Software & Gaming · MindsEye had a lot going for it pre-launch. The game was a new open-world shooter produced by former Rockstar alumni but the game launched in a rough state and ultimately flopped. Now, IO Interactive has spoken up about the ... Matthew Wilson 4 days ago Featured Tech News, Software & Gaming · MindsEye had a lot going for it pre-launch. The game was a new open-world shooter produced by former Rockstar alumni but the game launched in a rough state and ultimately flopped. Now, IO Interactive has spoken up about the project, which may have killed the company's future plans for publishing third-party games.Home / Tech News / Featured Tech News / IO Interactive hits the brakes on third-party publishing after MindsEye flopMindsEye was developed by Build a Rocket Boy, a new studio founded by former Rockstar producer, Leslie Benzies. However, IO Interactive acted as the publisher for this game.It was the first major third-party publishing deal at the company and because of the game's poor commercial and critical performance, IO is unsure if it will risk doing more publishing deals like this.
We cannot provide a description for this page right now
We deliver real-time business and markets news to the world covering FDA approvals, merger & acquisitions, earnings, dividends, SEC filings and more. Latest News Analyst Ratings SPACs & IPOsFDA ApprovalsMerger & Acquisitions
04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that members of its senior management team will provide a corporate update and participate in one-on-one ... NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, announced today that members of its senior management team will provide a corporate update and participate in one-on-one meetings at the following upcoming investor conferences:The company is currently conducting a pivotal Phase 3 trial (IOB-013/KN-D18; NCT05155254) investigating Cylembio in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) versus pembrolizumab alone in patients with advanced melanoma, a Phase 2 basket trial (IOB-022/KN-D38; NCT05077709) investigating Cylembio in combination with pembrolizumab as first line treatment in patients with advanced solid tumors, and a Phase 2 basket trial (IOB-032/PN-E40; NCT05280314) investigating Cylembio in combination with pembrolizumab as neo-adjuvant/adjuvant treatment of patients with solid tumors.IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment.Forward-looking statements, including statements regarding the timing or outcome of communications with regulatory authorities including the FDA, the timing or outcome of the submission of marketing applications, including a BLA, for Cylembio, the timing or outcome of the launch of Cylembio, and statements regarding other current or future clinical trials, their timing, progress, enrollment or results, or the company’s financial position or cash runway, are based on IO Biotech’s current assumptions and expectations of future events and trends, which affect or may affect its business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties.
IO Interactive has suggested that it will approach third-party publishing with significantly more caution in future, following MindsEye's disastrous launch. News · Written by Joseph Allen · Published: September 4, 2025 8:29 AM · Share: MindsEye publisher IO Interactive has suggested that the game's disastrous launch may have made the studio think twice about taking on third-party publishing contracts in the future.IO Interactive · Gaming Industry · Action Adventure · More News · Frosthaven Early Access Roadmap Promises New Heroes, Storylines, and More · 09-05-25 · Read article · Metal Gear Solid Delta: Snake Eater Hits 1m Sales · 09-05-25 · Read article · Civilization VII and Marvel's Midnight Suns Studio Firaxis Hit by Layoffs ·Speaking to IGN, IO Interactive CEO Hakan Abrak said that while his studio will continue to publish its own games, whether or not the IOI Partners label publishes any more third-party games "remains to be seen".Just in case you need a reminder, MindsEye, which is the debut project from the "multinational" studio Build a Rocket Boy, was IO Interactive's first external publishing effort, and it's safe to say the game's launch didn't exactly go as either studio had hoped it would.
The $6.5 billion deal brings together the maker of ChatGPT and one of the world's most famous product designers in a venture to create new AI-enabled devices. OpenAI buys io, former Apple designer Jony Ive’s device startup The $6.5 billion deal brings together the maker of ChatGPT and one of the world's most famous product designers in a venture to create new AI-enabled devices.The company announced that it is buying a device startup called io, launched by former Apple designer Jony Ive, in a deal worth just under $6.5 billion.Ive and his design firm LoveFrom, which he started after leaving Apple in 2019, will assume design and creative responsibilities across OpenAI and io, the announcement said.Prior to the deal, which OpenAI says is expected to close this summer, the company already owned 23% of io in a collaborative agreement forged last year.
OpenAI and Jony Ive are facing a lawsuit over their AI hardware project, and scrubbed posts referencing the IO name. See All News · OpenAI · Posts from this topic will be added to your daily email digest and your homepage feed.Follow · See All OpenAI · Tech · Posts from this topic will be added to your daily email digest and your homepage feed.Follow · See All Tech · See all · OpenAI closes its deal to buy Jony Ive’s io and build AI hardware ·OpenAI has scrubbed mentions of io, the hardware startup co-founded by famous Apple designer Jony Ive, from its website and social media channels.This page is temporarily down due to a court order following a trademark complaint from iyO about our use of the name ‘io.’ We don’t agree with the complaint and are reviewing our options.The blog post from Ive and Altman announcing the deal said, “The io team, focused on developing products that inspire, empower and enable, will now merge with OpenAI to work more intimately with the research, engineering and product teams in San Francisco.”
In a new interview with IGN, IO Interactive CEO Hakan Abrak said the initial talks it had with Build a Rocket Boy was “to support them”, explaining: “We thought they had some great ideas and a great world in the background that they were building, and hopefully they’ll get the opportunity ... Video Game News · 4th Sep 2025 / 10:36 am · Posted by Chris Scullion · The CEO of Hitman developer IO Interactive (IOI) says the disastrous launch of MindsEye has left the company’s future publishing plans in question. In 2017, IOI performed a management buyout from then-owner Square Enix, making the company fully independent.In a new interview with IGN, IO Interactive CEO Hakan Abrak said the initial talks it had with Build a Rocket Boy was “to support them”, explaining: “We thought they had some great ideas and a great world in the background that they were building, and hopefully they’ll get the opportunity to show more of that in the future.It was a tough reception. It wasn’t what they hoped for, and also what we didn’t hope for at IOI Partners. They’re working hard on turning that around to regain the trust of the gamers out there, and they have tons of potential and content they’re working on.IOI’s publishing plans took a step further in 2024 when the company announced IOI Partners, a new venture that would see it publishing games from other developers.
News IO is a publishing company that provides business, entertainment, environment, and political news. News IO is a news printing company.There is no recent news or activity for this profile.Their categories include business, entertainment, environment, politics, science, sports, technology, and world news.
IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's progression in a late-stage study, but narrowly missed the main goal as the results did not show statistical significance. My News · Register · By Sneha S K and Siddhi MahatoleAugust 12, 20251:40 PM UTCUpdated ago · Merck and Keytruda logos are seen in this illustration taken March 26, 2025. REUTERS/Dado Ruvic/Illustration Purchase Licensing Rights, opens new tab · Companies · Bristol-Myers Squibb Co · Follow · IO Biotech Inc ·Aug 11 (Reuters) - IO Biotech (IOBT.O), opens new tab said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's progression in a late-stage study, but narrowly missed the main goal as the results did not show statistical significance.IO Biotech was testing the vaccine, in combination with Merck's (MRK.N), opens new tab Keytruda, in 407 patients having advanced melanoma.IO Biotech plans to meet with the U.S.
Google I/O 2025 was full of tons of announcements, lots of launches and plenty of demos! And if you just can’t get enough of all things I/O, you can dive deeper into the… Understand all the I/O news with NotebookLM.Google I/O 2025 was full of tons of announcements, lots of launches and plenty of demos! And if you just can’t get enough of all things I/O, you can dive deeper into the news with NotebookLM.Everything’s uploaded there so you can ask NotebookLM to help you make sense of it. You can explore I/O announcements in a Mind Map, FAQ or listen to an Audio Overview. Ask the notebook questions ("what were the top Android announcements?") or instruct NotebookLM to generate a summary in any format ("draft a social post on Gemini news").Let’s stay in touch. Get the latest news from Google in your inbox.
Access Messari's trusted crypto research, reports, AI news summaries, real-time price, token unlocks, and fundraising data to navigate the cryptocurrency space insightfully. News · Sectors · Research · Videos & Podcasts · AI Recap · Fundraising · Token Unlocks · Trending Topics · Key Developments · Market Overview 24H · Marketcap · $4.12T0.67% Volume · $46.70B8.85% Dominance · 54.33%0.30% 12.7%0.12% Close · Limited · All ·
MindsEye's catastrophic failure forces IO Interactive to reconsider publishing future. CEO questions IOI Partners after 40% Steam reviews disaster. IO Interactive learned this lesson the hard way, and their potential retreat from third-party publishing would mark the end of what could have been an exciting chapter in their company's evolution. Sometimes, the best business decision is knowing when to cut your losses and refocus on what you do best. More Articles · Gaming Industry Updates 2025: Kojima & Blizzard News ·News 5th September, 2025 · Is MindsEye so bad that IO Interactive is done publishing other developers' games?MindsEye's disastrous launch has IO Interactive CEO Hakan Abrak expressing serious doubts about the future of IOI Partners, their third-party publishing initiative, after the game became one of 2025's worst-rated releases with just 40% positive Steam reviews.Having analyzed the fallout extensively, I can tell you this isn't just another bad game launch – it's a cautionary tale about the risks established studios face when venturing into third-party publishing. What makes this situation especially painful is watching IO Interactive, creators of the beloved Hitman franchise, potentially abandoning their publishing ambitions after just one catastrophic attempt.